Events at Borealis
In addition to the main conference, we are planning a series of satellite events, workshops, webinars and gatherings designed to expand your understanding and help you connect with the psychedelic science community.
Psychedelics for Anxiety Disorders with Dr. Louma
September 16th - 19:00
The potential of psychedelics in treating anxiety disorders is capturing increasing attention from researchers and clinicians worldwide. With a groundbreaking clinical trial investigating MDMA-assisted therapy for Social Anxiety Disorder, clinical psychologist Jason Luoma has been a pioneering figure in exploring how psychedelics might transform our approach to anxiety. But how can psychedelic treatments extend beyond MDMA, and what role might therapies like Acceptance and Commitment Therapy (ACT) play in managing anxiety and avoidance?
Workshop on Mindfulness-Based Psychedelic Integration
September 24th - 14:00-19:00
Join Nir Tadmor, Borealis, and Föreningen för Psykedelisk Terapi for a pre-conference workshop exploring how mindfulness supports psychedelic integration. Learn the MBPI model through theory, group exercises, and case studies, designed for clinicians and professionals working with psychedelic experiences.
Workshop on Enhancing Psychedelic-Assisted Therapy with ACT
September 25th - 09:00-17:00
Led by ACT researcher Jason Luoma, PhD, this full-day workshop at Elite Hotel Marina Tower teaches clinicians how to apply ACT’s six core processes, acceptance, defusion, present-moment awareness, self-as-context, values, and committed action, to the preparation, dosing, and integration phases of psilocybin, MDMA, and ketamine-assisted therapy. Through concise lectures and hands-on exercises, you’ll learn evidence-based strategies for fostering psychological flexibility, navigate key ethical and cultural considerations, and build practical skills, all over a gourmet lunch and traditional Swedish fika.
Movie Screening - Stepping into the Unknown
September 26th - 19:00
Stepping into the Unknown follows Dr Liknaitzky and his team at Monash University which conducts a trial with psilocybin to treat patients with generalised anxiety disorder. The documentary follows their journey through treatment, including psychedelic dosing sessions, and intense and intimate therapy.
MDMA in Psychiatry - Challenges and Possibilites Ahead with Dr. Holland
August 13th - 19:00
Led by psychiatrist and psychopharmacology expert Dr. Julie Holland in conversation with clinical psychologist Filip Bromberg, this webinar examines the fallout from the FDA’s unexpected 2024 rejection of MDMA-assisted therapy and explores what comes next for clinicians and researchers. You’ll dive into whether further Phase 3 trials are needed, the clinical and ethical dilemmas at hand, harm-reduction strategies, and the therapeutic relationship’s role in MDMA therapy. Join us for a critical, forward-looking dialogue on lessons for Sweden and the global psychedelic community as we navigate this pivotal moment.
